==============
















 TECHNICAL
  RESEARCH

      LINKS

     EMAIL

AMAZING OFFER

ORDER HERE

VIGEl™   SCIENTIFIC EVIDENCE - SEXUAL RESEARCH

Vigel Beginning   Vigel Into   Vigel Research   Vigel Instructions    Vigel Directions   Vigel Information
Vigel and Female Sexual Dysfunction   Vigel and FSAD   Vigel and Pleasure Use    Order Vigel Here

VIGEl has received rave reviews from women who have no sexual dysfunction but appreciate the product nonetheless because it helps them have more intense sexual excitement and frequent orgasms.

VIGEl, however, has demonstrated its true strength in the following double blind studies conducted on post-menopausal and sexually dysfunctional women including women diagnosed with F.S.A.D., (Female Sexual Arousal Disorder)  These groups also included women in general, who were experiencing inadequate, or unsatisfactory orgasms or inadequate frequency and/or intensity of orgasms or women who simply considered themselves lacking in their desired level of sexual satisfaction.

What is F.S.A.D?

Female Sexual Arousal Disorder (FSAD) is a persistent or recurrent inability to attain, or to maintain until completion of the sexual activity, an adequate lubrication-swelling response of sexual excitement. This "response" involves vaginal lubrication, expansion of the vagina, and swelling of the external genitalia. The disturbance must cause marked distress or interpersonal difficulty. The dysfunction is also not better accounted for by another problem and is not due exclusively to the direct physical effects of a substance (i.e. an illegal drug or prescription medication) or a medical condition.

SUMMARIES OF CLINICAL TRIALS

One study on L-Arginine was conducted on post-menopausal women with Female Sexual Arousal Disorder or FSAD. The study was designed to determine the effects on vaginal blood flow and sexual arousal of the Nitric Oxide-precursor L-Arginine (as well as other substances) on physiological responses to erotic stimuli in post -menopausal women who had experienced FSAD for at least 6 months.  This is the same L-Arginine found in the VIGEl formula for women.

The study was a randomized, double-blind, placebo-controlled, three-way crossover clinical trial. Patients were 23 post-menopausal women who met DSM IV criteria for FSAD. The physiological sexual arousal of the subjects was measured by changes in vaginal pulse amplitude using a method called Vaginal Photoplethysmography.

The subjects were shown a neutral (non-sexual movie) as well as a film with sexual content. The degree of each subject's sexual reaction to the neutral as well as to the sexual movie was measured by the Vaginal Photoplethysmography technology. Subjective sexual arousal was also gauged by using a Self-Report Questionnaire that was standardized for all woman involved in the trial.

The results of the Vaginal Photoplethysmography showed a rapid and significant increase in Vaginal Pulse Amplitude Response (meaning the subject's degree of sexual stimulation) to the erotic film after the L-Arginine was administered as compared to the placebo group. The Self-Report Questionnaire yielded similar results. The research study demonstrated   that the mechanism responsible for the increase in sexual arousal was the body's enhanced production of Nitric Oxide due to the administration of L-Arginine.

The increased Nitric Oxide release caused the women who were given L-Arginine to be significantly more stimulated by the erotic content of the sexual film as opposed to those subjects who received the placebo.

The results of another clinical study of L-Arginine were presented at the Ninth Annual Congress on Women's Health & Gender-Based Medicine in Washington, D.C. The study indicated significant improvement in women's sexual desire and overall satisfaction. In this double-blind placebo-controlled study, 93 women, ages 22-73, enrolled as participants lacking in sexual desire or self diagnosed with FASD.

Of the 93 women involved, 46 received L-Arginine and 47 received a placebo. The participants used a Female Sexual Function Index Questionnaire to rate their level of sexual health before starting the study and after taking either a placebo or the L-Arginine.

At the end of four weeks, 62 percent of the active group of women reported significantly improved satisfaction with their overall sex life and 64 percent reported an improvement in their overall level and intensity of sexual desire

    SEX RESEARCH - VIGEL WORKS!
93 women, ages 22-73, participated in a double-blind, placebo-controlled study to determine the effectiveness of the L-Arginine found in VIGEL Sexual Enhancement Cream.   Theses are the results:

ViGel for Women   -   - An Exciting Sexual Gel that Increases Feminine Sexual Sensation and Pleasure and Enhances Female Sexual Arousal! 
Get the "Excitement" Back Into Your Sex Life Now. Its your turn!
Get the "Excitement" Back Into Your Sex Life Now. Its your turn!
VIGEl is Guaranteed to Enhance Your Sexual Excitement or Your Money Back
   VIGEl costs $24.95 per bottle-Regular Price $29.95  (approximately 30 applications).
       VIGEl will be shipped discreetly and confidentially to your door in plain packaging  
          VIGEl for Women - Sexual Excitement in a Bottle - Order it Now
                Vigel Beginning   Vigel Into    Vigel Research   Vigel Instructions   Vigel Directions   Vigel Information
               Vigel & Female Sexual Dysfunction   Vigel &  FSAD   Vigel & Pleasure Use   Order Vigel Here                Vigel Beginning   Vigel Into    Vigel Research   Vigel Instructions   Vigel Directions   Vigel Information
               Vigel & Female Sexual Dysfunction   Vigel &  FSAD   Vigel & Pleasure Use   Order Vigel Here   Next Page